BACKGROUND: The use of generic medicines instead of branded, is one of the main
policies to decrease the expenditures and provide access to affordable and essential …

Introduction: There are appreciable concerns among European health authorities with
growing expenditure on cancer medicines and issues of sustainability. The enhanced use of …

Purpose The paper aims to study how global pharmaceutical companies such as Pfizer
have managed the challenges of pharmaceutical patent expiry. Design/methodology …

Purpose Generic drugs use in the Liguria region is higher than the Italian average, but lower
than in other European countries. No data exist about real-life prescription and level of …

This study probed the market share of generic medicines by patients' age and sex, type of
medical facilities, route of administration, number of generic brands, market size (drug …

Background: Generic drug prices have been capped at specified percentages of the
interchangeable branded drug's price by the Canadian provincial public drug plans since …

Introducción: Existen pocos datos sobre la utilización de genéricos y la sustitución de
genéricos en Perú, por lo que es importante explorar la opinión y la práctica de los …

Introduction The aim of the study was to evaluate, in a regulated generics market, the effect
of the number of manufacturers of generic drugs on the amplitude of off-patent products …

In recent years, laws and public initiatives have encouraged the use of equivalent drugs,
although in some cases poorly organized projects resulted in discontent among doctors and …